[Experience in the treatment of water-salt retentions in cirrhosis by the antialdosterone 11614 R.P].
作者信息
Boivin P, Fauvert R
出版信息
Rev Int Hepatol. 1969;19(4):241-51.
PMID:5404532
Abstract
摘要
相似文献
1
[Experience in the treatment of water-salt retentions in cirrhosis by the antialdosterone 11614 R.P].
Rev Int Hepatol. 1969;19(4):241-51.
2
3
Use of a new diuretic agent (metolazone) in patients with edema and ascites.
Arch Intern Med. 1973 Jul;132(1):38-41.
4
[Study of the new diuretic: Amiloride (MK-870)].新型利尿剂阿米洛利（MK - 870）的研究
Praxis. 1969 Sep 23;58(38):1192-6.
5
[Therapy of the water and electrolyte balance disorders with Hydromedine].[用海多明治疗水和电解质平衡紊乱]
Med Klin. 1967 Apr 14;62(15):604-9.
6
High doses of spironolactone (Aldactone, SC-14266, Verospirone) alone and in combination with triamterene and-or diuretics in the treatment of refractory edema associated with secondary hyperaldosteronism.高剂量螺内酯（安体舒通、SC - 14266、维螺酮）单独使用以及与氨苯蝶啶和/或利尿剂联合使用治疗与继发性醛固酮增多症相关的难治性水肿。
Endokrinologie. 1970;57(1):46-62.
7
Clinical experience with furosemide.速尿的临床经验。
South Med J. 1968 Oct;61(10):1083-8. doi: 10.1097/00007611-196810000-00015.
8
Combined ascitic-fluid and furosemide infusion in the management of ascites.联合腹水和呋塞米输注治疗腹水
N Engl J Med. 1970 Mar 26;282(13):713-7. doi: 10.1056/NEJM197003262821304.
9
Kinetics and dynamics of triamterene at steady-state in patients with cirrhosis.
Clin Invest Med. 1988 Feb;11(1):6-9.
10
[Therapeutic report on an injectable aldosterone antagonist (K-canrenoate) in states of water-salf retention].[注射用醛固酮拮抗剂（K-坎利酸钾）对水盐潴留状态的治疗报告]
Clin Ter. 1976 Feb 15;76(3):215-34.
Zotero 插件